The threat of mid-Spectrum chemical warfare agents

Prehospital and Disaster Medicine

Volumn 18, Issue 4, 2003, Pages 306-312

  Aas, På ^a,b  

^a NORWEGIAN DEFENCE RESEARCH ESTABLISHMENT FFI   (Norway)

^b UNIVERSITY OF BERGEN   (Norway)

Author keywords

biological warfare agents; bioregulators; biotoxins; chemical warfare agents; disarmament; genocidal agents; synthetic viruses; toxic industrial chemicals

Indexed keywords

BIOLOGICAL PRODUCT; TOXIN;

CHEMICAL INDUSTRY; CHEMICAL WARFARE; CHEMISTRY; CLASSIFICATION; DRUG INDUSTRY; HUMAN; INTERNATIONAL COOPERATION; REVIEW; TERRORISM;

BIOLOGICAL PRODUCTS; CHEMICAL INDUSTRY; CHEMICAL WARFARE; DRUG INDUSTRY; HUMANS; INTERNATIONAL COOPERATION; TERRORISM; TOXINS, BIOLOGICAL;

EID: 4344602878     PISSN: 1049023X     EISSN: 19451938     Source Type: Journal    
DOI: 10.1017/S1049023X00001254     Document Type: Article

References (25)

1. Pearson GS: The Technical Challenge to Counter the CBW Spectrum. In: Proceedings of the Third International Symposium on Protection against Chemical Warfare Agents, Umea, Sweden 1989, pp 375-383.
2. Chemical Weapons Convention, 1993: Convention on the Prohibition of the Developmen t, Production, Stockpiling and the Use of Chemical Weapons and on Their Destruction. Signed in Paris 13 January 1993.
3. The Biological and Toxin Weapons Convention, 1972. The Convention on the Prohibition of the Developmen t, Production and Stockpiling of Bacteriological (Biological) and Toxin Weapons and on their Destruction. Signed in Washington, London, and Moscow, 10 April 1972.
4. Pearson GS: The prohibition of chemical and biological weapons. In: Dando MR, Pearson GS, Toth T (eds): Verification of the Biological and Toxin Weapons Convention. NATO-ASI Series. Disarmament Technologies. 2000;32, pp 1-31.
5. Goransson-Nyberg A, Hjalmarsso n K, Cassel G, Hammarstrom LG, Norlander L: Neurotoxins-Medical Research Device for New Pharmaceutical Drugs or Warfare Agents? FOA-Report 00-01535-862-SE 2000, Umea, Sweden.
6. Tucker J: Dilemmas of a dual-use technology: Toxins in medicine and warfare. Politics and the Life Sciences 1994:51-62.
7. Canadian Report, 199: Novel Toxins and Bioregulators: The emerging scientifically and technological issues relati ng to verification and the Biological Weapons Convention; September 1991, Ottawa, Canada.
8. United Nations: The United Nations and the Iraq-Kuwait Conflict, 1990- 1996. The United Nations Blue Book Series, Volume IX, Department of Public Information, United Nations, New York, USA, 1996.
9. Pearson G:The UNSCOM Saga: Chemical and Biological Weapons Non-proliferation. 1999. London, England: MacMillan Press Ltd.
10. United Nations Security Council: Note by the Secretary-General, The eight report submitted by The United Nations Special Commission under paragraph 8 of Security Council Resolution 715 (1991), S/1995/864,11 October 1995.
11. Cello J, Paul AV, Wimmer E: Chemical synthesis of poliovirus cDNA: Generation of infectious virus in the absence of natural template. Science 2002;297:1016-1018.
12. Jackson RJ, Ramsay AJ, Christensen, CD, Beaton S, Hall DF, Ramshaw IA: Expression of mouse interleukin-4 by a recombinant ectomelia virus suppresses cytocolic lymphocyte responses and overcomes genetic resistance to mousepox. J of Virology 2001;75(3):1205-1210.
13. Initial sequencing and analysis of the human genome. Nature 2001;409: 860-921.
14. Nixdorff K,Brauburger J,Hahlbohm D, The Biotechnology Revolution: The Science and Applications. In Dando MR, Pearson GS, Toth T (eds.), Verification of the Biological and Toxin Weapons Convention. NATO AS1 Series, 2000, 32, 77-124.
15. Bartfai T, Lundin SJ, Rybeck B: Benefits and Threats of Developments in Biotechnology and Genetic Engeneering. SIPRI Yearbook 1993; 1993; 293-305.
16. Holden C: Soviet biowarfare apparatus: All gone? Science 1992;257:1866.
17. Mahant N, Clouston PD, Lorentz IT: The current use of botulinum toxin.-/Clin Neurosci 2000;7(5):389-394.
18. Savarese JJ: The new neuromuscular blocking drugs are here./Anes
19. Schachter M: Moxonidine: A review of safety and tolerability after seven years of clinical experience. J Hypertension 1999;17(3):S37-S39.
20. Aas P: UNSCOM's and IAEA's disarmament of Iraq's weapons of mass destruction. InternasjonalPolitikk 1997;55(1):41-60.
21. The CBW Conventions Bulletin. "Law enforcement" and the CWC, Issue no 58, 2002.
22. OPCW, 2001: Report of the OPCW on the Implementation of the Convention on the Prohibition of the Development, Production, Stockpiling, and Use of Chemical Weapons and on Their Destruction in the year 2000.
23. OPCW, 2002: Draft Report of the OPCW on the Implementation of the Convention on the Prohibition of the Development, Production, Stockpiling, and Use of Chemical Weapons and on Their Destruction in the year 2001.
24. Pearson GS, Magee RS: Critical evaluation of proven chemical weapons destruction technologies (IUPAC Technical Report). Pure Appl Chem 2002;74(2):187-316.
25. Zajtchuk R, Bellamy RF: Textbook of Military Medicine: Medical Aspects of Chemical and Biological Warfare. Published by the office of The Surgeon General at TTM Publications, Bordon Institut e, Walter Reed Army Medical Center: Washington DC, 1997.